| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 17 |
| 1 | ADALIMUMAB | 15 |
| 2 | RISANKIZUMAB-RZAA | 12 |
| 3 | PREDNISONE | 9 |
| 4 | MESALAMINE | 6 |
| 5 | METFORMIN | 6 |
| 6 | OMEPRAZOLE | 6 |
| 7 | OMEPRAZOLE MAGNESIUM | 6 |
| 8 | DIPHENHYDRAMINE HYDROCHLORIDE | 5 |
| 9 | METFORMIN ER 500 MG | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIPROFLOXACIN AND DEXAMETHASONE | 1 | 0.0130 |
| 1 | I. V. FAT EMULSION | 1 | 0.0014 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 3 | TESAMORELIN | 2 | 0.0012 |
| 4 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 5 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 6 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 7 | UREA | 1 | 0.0005 |
| 8 | LEMBOREXANT | 1 | 0.0003 |
| 9 | ICATIBANT ACETATE | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 19 |
| 1 | Interleukin-23 Antagonist [EPC] | 15 |
| 2 | Corticosteroid [EPC] | 10 |
| 3 | Proton Pump Inhibitor [EPC] | 9 |
| 4 | Aminosalicylate [EPC] | 7 |
| 5 | Vitamin B12 [EPC] | 7 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| 8 | Janus Kinase Inhibitor [EPC] | 5 |
| 9 | Vitamin C [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 1 | Integrin Receptor Antagonist [EPC] | 19 | 0.0002 |
| 2 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 3 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 2 | 0.0001 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Interleukin-23 Antagonist [EPC] | 15 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 7 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 9 | Anti-anginal [EPC] | 1 | 0.0001 |